Mirco Ponzoni mainly investigates Neuroblastoma, Cancer research, Pathology, Cell culture and Apoptosis. His Neuroblastoma research includes themes of Angiogenesis, Liposome, Chemotherapy, Doxorubicin and In vivo. The Cancer research study combines topics in areas such as Cytotoxic T cell and Cell growth.
Mirco Ponzoni combines subjects such as Endocrinology, Internal medicine and Propidium iodide with his study of Cell growth. His research in Pathology intersects with topics in Macrophage and Neovascularization. His research integrates issues of Methylation, Gene, DNA methylation, Molecular biology and Promoter in his study of Cell culture.
The scientist’s investigation covers issues in Neuroblastoma, Cancer research, Cell culture, In vivo and Molecular biology. His Neuroblastoma research integrates issues from In vitro, Liposome, Doxorubicin, Pathology and Pharmacology. His work carried out in the field of Cancer research brings together such families of science as Immunology, Apoptosis, Cell growth and Fenretinide.
His Cell culture study combines topics from a wide range of disciplines, such as Endocrinology, Cellular differentiation, Biochemistry, Internal medicine and Cell biology. In his research on the topic of In vivo, Targeted therapy is strongly related with Nanocarriers. His Molecular biology research incorporates themes from Gene expression, Gene and Oncogene.
Mirco Ponzoni focuses on Neuroblastoma, Cancer research, In vitro, In vivo and Nanocarriers. His Neuroblastoma research is classified as research in Cell culture. His study of Angiogenesis is a part of Cancer research.
His study looks at the relationship between In vitro and fields such as Doxorubicin, as well as how they intersect with chemical problems. Mirco Ponzoni works mostly in the field of In vivo, limiting it down to topics relating to Cytotoxicity and, in certain cases, Toxicity, Biophysics, Autophagy, Tyrosine kinase and Viability assay, as a part of the same area of interest. His Nanocarriers research is multidisciplinary, relying on both Receptor, Integrin, Biochemistry, Cell biology and Deamidation.
His primary areas of investigation include Cancer research, Neuroblastoma, Immunology, Cancer and Cancer cell. His study in Cancer research is interdisciplinary in nature, drawing from both Targeted therapy, Targeted drug delivery, Nanocarriers, Drug and Pediatric cancer. In his works, Mirco Ponzoni undertakes multidisciplinary study on Neuroblastoma and Isotretinoin.
His work deals with themes such as Clodronic acid and Phenotype, which intersect with Immunology. His work carried out in the field of Cancer brings together such families of science as Adipose tissue, Antibody, Mesenchymal stem cell and Bone marrow. His work in Cancer cell addresses subjects such as Mutant, which are connected to disciplines such as In vitro.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Vascular Damage and Anti-angiogenic Effects of Tumor Vessel-Targeted Liposomal Chemotherapy
Fabio Pastorino;Chiara Brignole;Danilo Marimpietri;Michele Cilli.
Cancer Research (2003)
Macrophages are alternatively activated in patients with endometriosis and required for growth and vascularization of lesions in a mouse model of disease.
Monica Bacci;Annalisa Capobianco;Antonella Monno;Lucia Cottone.
American Journal of Pathology (2009)
Targeting liposomal chemotherapy via both tumor cell-specific and tumor vasculature-specific ligands potentiates therapeutic efficacy.
Fabio Pastorino;Chiara Brignole;Daniela Di Paolo;Bice Nico.
Cancer Research (2006)
Expression of ΔNp73 is a molecular marker for adverse outcome in neuroblastoma patients
I Casciano;K Mazzocco;L Boni;G Pagnan.
Cell Death & Differentiation (2002)
Differential effects of N-(4-hydroxyphenyl)retinamide and retinoic acid on neuroblastoma cells: apoptosis versus differentiation.
Mirco Ponzoni;Paola Bocca;Valeria Chiesa;Andrea Decensi.
Cancer Research (1995)
Phase I trial and pharmacokinetics of fenretinide in children with neuroblastoma.
Alberto Garaventa;Roberto Luksch;Maria Serena Lo Piccolo;Elena Cavadini.
Clinical Cancer Research (2003)
Doxorubicin-loaded Fab′ Fragments of Anti-disialoganglioside Immunoliposomes Selectively Inhibit the Growth and Dissemination of Human Neuroblastoma in Nude Mice
Fabio Pastorino;Chiara Brignole;Danilo Marimpietri;Puja Sapra.
Cancer Research (2003)
Antiproliferative and pro-apoptotic activity of eugenol-related biphenyls on malignant melanoma cells.
Marina Pisano;Gabriella Pagnan;Monica Loi;Maria Elena Mura.
Molecular Cancer (2007)
Spot overlapping in two‐dimensional maps: A serious problem ignored for much too long
Natascia Campostrini;Liliana B. Areces;Juri Rappsilber;Maria Chiara Pietrogrande.
Effect of Bortezomib on Human Neuroblastoma Cell Growth, Apoptosis, and Angiogenesis
Chiara Brignole;Danilo Marimpietri;Fabio Pastorino;Beatrice Nico.
Journal of the National Cancer Institute (2006)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: